SitesBLAST
Comparing WP_012674117.1 NCBI__GCF_000021545.1:WP_012674117.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
P00903 Aminodeoxychorismate synthase component 2; ADC synthase; ADCS; 4-amino-4-deoxychorismate synthase component 2; Aminodeoxychorismate synthase, glutamine amidotransferase component; EC 2.6.1.85 from Escherichia coli (strain K12) (see paper)
60% identity, 94% coverage: 1:187/198 of query aligns to 1:186/187 of P00903
- C79 (= C80) mutation to S: 10000-fold decrease in catalytic efficiency.
- H168 (= H169) mutation to Q: Loss of activity.
- E170 (= E171) mutation to A: 150-fold decrease in catalytic efficiency.; mutation to D: 4-fold decrease in catalytic efficiency.; mutation E->K,Q: Loss of activity.
Q42565 Anthranilate synthase beta subunit 1, chloroplastic; Anthranilate synthase component 2-1; Anthranilate synthase, glutamine amidotransferase component 2-1; Protein TRYPTOPHAN BIOSYNTHESIS 4; Protein WEAK ETHYLENE INSENSITIVE 7; EC 4.1.3.27 from Arabidopsis thaliana (Mouse-ear cress) (see 2 papers)
51% identity, 97% coverage: 2:194/198 of query aligns to 75:272/276 of Q42565
- G150 (= G78) mutation to D: In trp4-1; no visible phenotype under normal growth conditions.
- G176 (= G103) mutation to E: In wei7-2; insensitive to inhibition of root elongation by ethylene.
8hx8A Crystal structure of 4-amino-4-deoxychorismate synthase from streptomyces venezuelae co-crystallized with chorismate (see paper)
47% identity, 94% coverage: 3:189/198 of query aligns to 7:191/673 of 8hx8A
Sites not aligning to the query:
- binding magnesium ion: 521, 655, 658
- binding tryptophan: 231, 232, 233, 241, 243, 458, 459, 460, 614
P00900 Anthranilate synthase component 2; AS; ASII; Anthranilate synthase, GATase component; Anthranilate synthase, glutamine amidotransferase component; EC 4.1.3.27 from Serratia marcescens (see 3 papers)
42% identity, 95% coverage: 2:189/198 of query aligns to 4:190/193 of P00900
- C84 (= C80) active site, Nucleophile; for GATase activity
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
1i7qB Anthranilate synthase from s. Marcescens (see paper)
41% identity, 95% coverage: 2:189/198 of query aligns to 3:189/192 of 1i7qB
- active site: G58 (≠ C55), C83 (= C80), L84 (= L81), H169 (= H169), E171 (= E171)
- binding glutamic acid: P55 (= P52), G56 (= G53), G58 (≠ C55), C83 (= C80), L84 (= L81), Q87 (= Q84), H132 (= H129), S133 (= S130), L134 (= L131)
8hx9A Crystal structure of 4-amino-4-deoxychorismate synthase from streptomyces venezuelae with chorismate (see paper)
38% identity, 94% coverage: 3:189/198 of query aligns to 6:148/632 of 8hx9A
Sites not aligning to the query:
- binding (3R,4R)-3-[(1-carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylic acid: 453, 454, 455, 456, 547, 570, 590, 603, 604, 605, 606, 619, 623
- binding tryptophan: 189, 190, 191, 199, 201, 419, 420, 421, 574, 575
7yc6A Crystal structure of d110p mutant of gatase subunit of methanocaldococcus jannaschii gmp synthetase
36% identity, 93% coverage: 1:185/198 of query aligns to 1:174/183 of 7yc6A
Q9LVW7 Carbamoyl phosphate synthase small chain, chloroplastic; Carbamoyl phosphate synthetase glutamine chain; Protein VENOSA 6; EC 6.3.5.5 from Arabidopsis thaliana (Mouse-ear cress) (see paper)
27% identity, 96% coverage: 6:196/198 of query aligns to 235:430/430 of Q9LVW7
- H410 (≠ Y177) mutation to Y: In ven6-1; reticulate leaf phenotype.
P0A6F1 Carbamoyl phosphate synthase small chain; Carbamoyl phosphate synthetase glutamine chain; EC 6.3.5.5 from Escherichia coli (strain K12) (see paper)
30% identity, 95% coverage: 9:197/198 of query aligns to 188:382/382 of P0A6F1
- G241 (= G53) binding L-glutamine
- G243 (≠ C55) binding L-glutamine
- L270 (= L81) binding L-glutamine
- Q273 (= Q84) binding L-glutamine
- N311 (≠ Y128) binding L-glutamine
- G313 (≠ S130) binding L-glutamine
- F314 (≠ L131) binding L-glutamine
Sites not aligning to the query:
1ce8B Carbamoyl phosphate synthetase from escherichis coli with complexed with the allosteric ligand imp (see paper)
30% identity, 94% coverage: 9:195/198 of query aligns to 187:379/379 of 1ce8B
Sites not aligning to the query:
1c3oB Crystal structure of the carbamoyl phosphate synthetase: small subunit mutant c269s with bound glutamine (see paper)
29% identity, 94% coverage: 9:195/198 of query aligns to 187:379/379 of 1c3oB
- active site: K201 (≠ G23), S268 (≠ C80), H352 (= H169), E354 (= E171)
- binding glutamine: N239 (≠ P52), G240 (= G53), G242 (≠ C55), S268 (≠ C80), L269 (= L81), N310 (≠ Y128), H311 (= H129), G312 (≠ S130), F313 (≠ L131)
Sites not aligning to the query:
2ywcA Crystal structure of gmp synthetase from thermus thermophilus in complex with xmp
28% identity, 95% coverage: 1:189/198 of query aligns to 1:184/475 of 2ywcA
Sites not aligning to the query:
Q09794 Multifunctional protein ura1; Pyrimidine-specific carbamoyl phosphate synthase-aspartate carbamoyl transferase; CPSase-ATCase; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2 from Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) (see paper)
30% identity, 86% coverage: 2:172/198 of query aligns to 265:425/2244 of Q09794
Sites not aligning to the query:
- 1119 modified: Phosphoserine
- 1881 modified: Phosphoserine
- 1885 modified: Phosphoserine
Q18990 Multifunctional protein pyr-1; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2; EC 3.5.2.3 from Caenorhabditis elegans (see 3 papers)
31% identity, 64% coverage: 46:171/198 of query aligns to 219:341/2198 of Q18990
Sites not aligning to the query:
- 1602 H→Q: In cu8; probable loss of dihydroorotase activity. Severe late stage embryonic lethality in 50% of animals. The few surviving mutants have a shorter and thicker pharyngeal isthmus, an abnormal knobbed tail, mild egg-laying defects, moderate fluid accumulation in the coelom and a slower growth. Actin and intermediate filaments are disorganized in the pharynx. Moderate reduction in heparan sulfate levels and increased levels of chondroitin sulfate. In an umps-1 zu456 mutant background, prevents the formation of abnormally enlarged gut granules in embryos. Complete embryonic lethality in a rnst-2 qx245 mutant background.
P27708 Multifunctional protein CAD; Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2; EC 3.5.2.3 from Homo sapiens (Human) (see 7 papers)
28% identity, 73% coverage: 27:171/198 of query aligns to 193:338/2225 of P27708
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
- 2 modified: N-acetylalanine
- 33 M → R: in DEE50; uncertain significance; dbSNP:rs751610198
- 177 R → Q: in a colorectal cancer sample; somatic mutation; dbSNP:rs374122292
- 456 modified: Phosphothreonine; by MAPK1
- 735 Y → C: in a colorectal cancer sample; somatic mutation
- 1406 modified: Phosphoserine; by PKA
- 1471 binding Zn(2+); binding Zn(2+); H→A: No zinc-binding and no catalytic activity.; H→N: Abolishes dihydroorotase activity.
- 1473 binding Zn(2+); H→A: No zinc-binding and no catalytic activity.
- 1475 binding (S)-dihydroorotate
- 1505 binding (S)-dihydroorotate
- 1512 D→N: No change in catalytic activity.
- 1556 binding via carbamate group; binding via carbamate group; modified: N6-carboxylysine
- 1562 T→A: Abolishes dihydroorotase activity.
- 1563 F→A: Abolishes dihydroorotase activity.
- 1590 binding Zn(2+); H→A: Abolishes dihydroorotase activity.; H→N: No catalytic activity.
- 1613 binding Zn(2+); C→S: Reduces dihydroorotase activity.
- 1614 binding Zn(2+); H→A: Abolishes dihydroorotase activity.
- 1637 binding Zn(2+); E→T: Abolishes dihydroorotase activity.
- 1642 H→N: 11.5% of wild-type catalytic activity.
- 1661 binding (S)-dihydroorotate
- 1686 binding Zn(2+); D→N: Abolishes dihydroorotase activity.
- 1690 binding (S)-dihydroorotate; H→N: 3% of wild-type catalytic activity.
- 1702 binding (S)-dihydroorotate
- 1789:2225 natural variant: Missing (in DEE50; uncertain significance)
- 1859 modified: Phosphoserine; by RPS6KB1 and PKA
- 1873 modified: Phosphoserine; by PKC; in vitro; S→A: Abolishes PMA-induced Thr-456 phosphorylation.
- 1900 modified: Phosphoserine
P05990 Multifunctional protein r; Protein rudimentary; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2; EC 3.5.2.3 from Drosophila melanogaster (Fruit fly) (see 2 papers)
30% identity, 65% coverage: 43:171/198 of query aligns to 230:355/2224 of P05990
Sites not aligning to the query:
- 1167 E→K: Severely diminishes UTP inhibition of CPSase; in Su(b).
- 1883 modified: Phosphoserine
- 1885 modified: Phosphoserine
- 1892 modified: Phosphoserine
- 1894 modified: Phosphoserine
P08955 Multifunctional protein CAD; Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase; EC 6.3.5.5; EC 3.5.1.2; EC 6.3.4.16; EC 2.1.3.2; EC 3.5.2.3 from Mesocricetus auratus (Golden hamster) (see paper)
28% identity, 80% coverage: 13:171/198 of query aligns to 187:338/2225 of P08955
Sites not aligning to the query:
- 1406 modified: Phosphoserine; by PKA; S→A: No effect on enzyme kinetics.; S→D: Increases CPSase activity and reduces sensitivity to feedback inhibition by UTP.
3uowA Crystal structure of pf10_0123, a gmp synthetase from plasmodium falciparum
28% identity, 81% coverage: 34:193/198 of query aligns to 35:222/517 of 3uowA
Sites not aligning to the query:
P07258 Carbamoyl phosphate synthase arginine-specific small chain; CPS; CPSase; CPSase-arg; Arginine-specific carbamoyl phosphate synthetase, glutamine chain; Carbamoyl phosphate synthase A; CPS-A; Glutamine-dependent carbamoyl phosphate synthetase; EC 6.3.5.5 from Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) (see paper)
31% identity, 74% coverage: 27:172/198 of query aligns to 201:352/411 of P07258
- C264 (= C80) mutation to D: Abolishes glutamine-dependent CPSase activity.
- H307 (= H129) mutation to D: Abolishes glutamine-dependent CPSase activity.
- H349 (= H169) mutation to D: Abolishes glutamine-dependent CPSase activity.
Q8IJR9 GMP synthase [glutamine-hydrolyzing]; PfGMPS; Glutamine amidotransferase; Guanosine monophosphate synthetase; EC 6.3.5.2 from Plasmodium falciparum (isolate 3D7) (see 3 papers)
28% identity, 81% coverage: 34:193/198 of query aligns to 40:232/555 of Q8IJR9
- C89 (= C80) mutation to A: Loss of glutaminase activity, however, glutamine binding is not affected. In presence of exogenous ammonia, the amination of XMP to produce GMP is normal. 2.3-fold decrease in affinity for ATP and 1.8-fold decrease in affinity for XMP. 2.9-fold decrease in affinity for ATP and 1.9-fold decrease in affinity for XMP; when associated with A-113.
- Q93 (= Q84) binding L-glutamine
- C113 (vs. gap) mutation to A: 2.9-fold decrease in affinity for ATP and 1.9-fold decrease in affinity for XMP; when associated with A-89.
- K160 (≠ P120) mutation to L: No effect on glutaminase activity. 1.2-fold decrease in affinity for ATP. 1.8-fold decrease in affinity for XMP.
- W167 (≠ R127) mutation to F: Slight decrease in affinity for glutamine. Slight increase in glutaminase activity.
- N169 (≠ H129) binding L-glutamine; mutation to S: Slight increase in affinity for glutamine. No defect in glutaminase activity.
- D172 (= D134) binding L-glutamine; mutation to A: 172-fold decrease in affinity for glutamine. Severe loss of glutaminase activity.
- H208 (= H169) binding L-glutamine
- Y212 (≠ I173) mutation to W: 2.7-fold decrease in affinity for glutamine. No defect in glutaminase activity.
- E213 (≠ L174) mutation to A: 40 percent decrease in glutaminase activity. 1.4-fold decrease in affinity for glutamine. 1.3-fold decrease in affinity for ATP. 1.8-fold decrease in affinity for XMP.
Sites not aligning to the query:
- 18 Y→F: Slight increase in affinity for glutamine. No defect in glutaminase activity.
- 20 H→A: Slight decrease in affinity for glutamine. 1.8-fold increase in affinity for ATP. Slight increase in affinity for XMP. Moderate reduction in glutaminase activity.
- 24 K→L: 50 percent decrease in glutaminase activity. 5.3-fold decrease in affinity for glutamine. 1.7-fold increase in affinity for ATP. 2.8-fold decrease in affinity for XMP.
- 25 R→L: No effect on glutaminase activity. 1.4-fold decrease in affinity for glutamine.
- 336 binding XMP
- 371 Important for ATPPase activity; D→A: Impaired formation of adenyl-XMP intermediate. Slight increase in glutaminase activity.
- 374 E→L: 8.9-fold decrease in affinity for ammonia. Severe loss of glutaminase activity.
- 376 K→L: 20 percent decrease in glutaminase activity. 4.4-fold decrease in affinity for glutamine. 1.8-fold decrease in affinity for XMP.
- 386 K→L: Severe loss of ATP pyrophosphatase (ATPPase) activity. 80 percent decrease in glutaminase activity. Impaired GMP formation.
- 387 T→A: No effect on ATP pyrophosphatase (ATPPase) activity. 20 percent decrease in glutaminase activity. No effect on GMP formation.
- 388 Important for ATPPase activity; H→A: Moderate decrease in ATP pyrophosphatase (ATPPase) activity. Reduces 49 percent decrease in glutaminase activity. Impaired GMP formation.
- 389 Important for ATPPase activity; H→A: Loss of ATP pyrophosphatase (ATPPase) activity. 67 percent decrease in glutaminase activity. Impaired GMP formation.
- 390 N→A: No effect on ATP pyrophosphatase (ATPPase) activity. Increases glutaminase activity. Loss of GMP formation.
- 411 K→L: 70 percent decrease in glutaminase activity. Loss of GMP formation.
- 412 D→A: 30 percent decrease in glutaminase activity. 7.9-fold decrease in affinity for glutamine.
- 413 D→A: 35 percent decrease in glutaminase activity. 3.6-fold decrease in affinity for glutamine.
- 415 K→L: Increases glutaminase activity. 4.2-fold decrease in affinity for ATP.
- 476 binding XMP
- 539 R→L: 85 percent decrease in glutaminase activity.
- 547 binding XMP; K→L: 85 percent decrease in glutaminase activity.
- 552 binding XMP
- 553 binding XMP; E→L: 85 percent decrease in glutaminase activity.
- 555 E→L: 20 percent decrease in glutaminase activity. No effect on GMP formation.
Query Sequence
>WP_012674117.1 NCBI__GCF_000021545.1:WP_012674117.1
MILMIDNYDSFTYNIVQYFYELGQDVLVKRNDEITVEDIKRMDNVDAIVISPGPCTPNEA
GISVDVIKEFKGVYPILGVCLGHQSIGQAFGAKIVKAKCLMHGKTSKIYHNEKGLFEGIP
NPFNAVRYHSLVIDESTLPEDIEITARSDDGEIMAIQHKKYPIWGVQFHPESILTEYGLK
LLENFIHLAEKAKTTSKQ
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory